We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
Advertisement
 

RELATED ARTICLES

A Mother’s Touch Lingers in Her Child’s DNA

News

Mothers leave their mark on their children in many ways - and Australian researchers have discovered a protein called SMCHD1 is involved in this 'imprinting' process.

READ MORE

Model Designed To Predict Cellular Drug Targets Against COVID-19

News

A computational model of a human lung cell has been used to understand how SARS-CoV-2 draws on human host cell metabolism to reproduce.

READ MORE

CAR T-Cell Therapy Shows Promising Early Results in Children With Neuroblastoma

News

A novel CAR T-cell therapy has shown promising early results in children with neuroblastoma, a rare form of childhood cancer. Twelve children with relapsed or refractory neuroblastoma were treated as part of a Phase I clinical trial.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE